Positron emission tomography for preoperative staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 398-402

  Kosugi, Chihiro ^a,b   Saito, Norio ^a   Murakami, Koji ^a   Ochiai, Atsushi ^a   Koda, Keiji ^b   Ono, Masato ^a   Sugito, Masanori ^a   Ito, Masaaki ^a   Oda, Kenji ^b   Seike, Kazuhiro ^b   Miyazaki, Masaru ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Lymph node metastasis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 44349129770     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Staib L, Schirrmeister H, Reske SN, Beger HG: Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000; 180:1-5.
2. Takeuchi O, Saito N, Koda K, Sarashina H, Nakajima N: Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer. Br J Surg 1999; 86:932-937.
3. Johnson K, Bakhsh A, Young D, Martin E Jr, Arnold M: Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 2001; 44:354-357.
4. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB: Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206:755-760.
5. Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43:759-770.
6. Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA, Blatchford GJ: Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37:153-156.
7. Heriot AG, Hicks RJ, Drummond EG, Keck J, Mackay J, Chen F, Kalff V: Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004; 47:451-458.
8. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 1991; 32:623-650.
9. Price P: Positron emission tomography (PET) in diagnostic oncology: is it a necessary tool today? Eur J Cancer 2000; 36:691-693.
10. Arulampalam TH, Costa DC, Loizidou M, Visvikis D, Ell PJ, Taylor I: Positron emission tomography and colorectal cancer. Br J Surg 2001; 88:176-189.
11. Kantorova I, Lipska L, Belohlavek O, Visokai V, Trubac M, Schneiderova M: Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44:1784-1748.
12. Spinelli P, Schiavo M, Meroni E, Di Felice G, Andreola S, Gallino G, Belli F, Leo E: Results of EUS in detecting perirectal lymph node metastases of rectal cancer. Gastrointest Endosc 1999; 49:754-758.
13. Kim JC, Cho YK, Kim SY, Park SK, Lee MG: Comparative study of three-dimensional and conventional endorectal ultrasonography used in rectal cancer staging. Surg Endosc 2002; 16:1280-1285.